Shows
FavouredMike's PodcastDo not harden your heart. Dec. 25 Pd1 ||FavouredMike's PodcastDo not harden your heart. Believe God, Have a soft spot for His Word. Dec. 25 Pd1 ||FavouredMike's Podcast
2025-12-0113 min
Medical Digest & Congress ReportHow to optimize PD1/PDL1 treatment? - report from SITC 2025Professor Gordon J. Freeman shares his insights on how to optimize PD1/PDL1 treatment at SITC's 40th Anniversary Annual Meeting.Video: https://medicaldigest.org/scientific-contents/interview:how-optimize-pd1pdl1-treatment
2025-11-2708 min
FavouredMike's PodcastThat all men will be saved. Nov. 25 Pd1 ||FavouredMike's PodcastJesus Christ came that all men will be saved. Nov. 25 Pd1 ||FavouredMike's Podcast
2025-11-0413 min
FavouredMike's PodcastThe Savior will work miracles. Oct. 25 Pd1 ||FavouredMike's PodcastThe prophecy about the Savior being a miracle worker was fulfilled by Jesus. Oct. 25 Pd1 ||FavouredMike's Podcast
2025-10-0714 min
FavouredMike's PodcastThe Virgin birth prophecy fulfilled. Sept. 25 Pd1 ||FavouredMike's PodcastMysteries & Prophecies about Jesus. The Virgin birth prophecy fulfilled. Sept. 25 Pd1 ||FavouredMike's Podcast
2025-09-0110 min
FavouredMike's PodcastAll is Vanity, Prioritise your salvation. August 25 Pd1 ||FavouredMike's PodcastAll is Vanity, Prioritise your salvation. August 25 Pd1 ||FavouredMike's Podcast
2025-08-0414 minFavouredMike's PodcastJourneying to Destiny - Seek Counsel. July 25 Pd1 ||FavouredMike's PodcastJourneying to Destiny - Seek Counsel. July 25 Pd1 ||FavouredMike's Podcast
2025-07-0708 min
FavouredMike's PodcastAdd a touch of prayer. June Pd1 ||FavouredMike's PodcastAdd a touch of prayer. June Pd1 ||FavouredMike's Podcast
2025-06-0205 min
BiotechTV - NewsPfizer Chairman & CEO Dr. Albert Bourla discusses the company's bets on cancer research, VEGF x PD1, #ASCO25 data, and hot button issues affecting the biopharma industryDr. Bourla looks back on Pfizers $43B acquisition of Seagen and the company's more recent license of a VEGF x PD1 bispecific. He highlights ASCO data for BRAFTOVI, vepdegestrant, and XTANDI. Plus, his thoughts on the hot button issues of China biotech and biopharma's public reputation.
2025-05-3019 min
FavouredMike's PodcastThe Lord is with us. Let's Push On May25 Pd1The Lord is with us so let's keep pushing. May25 Pd1
2025-05-0703 min
The UromigosEpisode 399: A PD1/VEGF Bispecific in Lung Cancer - Lessons for GU Cancers?Dr. John Heymach from MD Andersons joins us to discuss a novel PD1/VEGF bispecific agent in lung cancer and if there are applicaitons in GU malignancies.
2025-03-2436 min
Melanoma MattersEp 62: Post PD-1 studiesSummaryOn mountain emergencies...Sapna's had them, James denies them...This conversation delves into the treatment options available for patients with advanced melanoma who have progressed after anti PD-1 therapy. The discussion covers various clinical studies, response rates, and the implications of combination therapy post-PD1 progression. James and Sapna conclude that while combination therapies show promise, the responses may not be as robust as those seen in frontline treatments.Keywordsmelanoma, PD-1, treatment, clinical trials, immunotherapy, BRAF, response rates, efficacy, combination therapy, patient outcomesTakeaways
2025-03-1819 min
Chat By The PitchGregg & Meagan: The Evolution of PD1 Soccer Training Part 2In this episode of Chat By The Pitch, we sit down with Gregg Megaw & Meagan Prewitt, the dynamic team behind PD1 Soccer Training, to discuss everything from player development and training structure to the business side of running a premier training academy.Gregg shares how he designs sessions that blend skill work with real-game application, while Meagan explains the importance of branding, structure, and keeping training organized and efficient. They also break down the mental side of the game, helping parents and players understand what it really takes to progress in competitive soccer.From helping...
2025-02-201h 03
Chat By The PitchGregg & Meagan: The Story Behind PD1 Soccer Training Part 1In this episode of Chat By The Pitch, we go behind the scenes of PD1 Soccer Training with Gregg Megaw & Meagan Prewitt, the duo who have built one of Texas’ premier skill training programs.Gregg, with his deep coaching experience from Northern Ireland to the U.S., shares his philosophy on technical training, player development, and the importance of structured training environments. Meagan, the mastermind behind PD1’s business operations, discusses the strategy behind growing a successful brand, managing logistics, and making training accessible for families.From coaching methodology to business strategy, this conversation is pack...
2025-02-131h 00
VJOncology PodcastTherapeutic options for PD1 refractory skin cancerIn this podcast, we explore the latest advancements in the treatment of PD-1 refractory melanoma. This week, we are joined by Allison Betof Warner (Stanford Cancer Center, Stanford, CA) and Omid Hamid (The Angeles Clinic and Research Institute, Los Angeles, CA) and Inderjit Mehmi (The Angeles Clinic and Research Institute, Los Angeles, CA).
We will hear about the clinical definitions and significance of PD-1 resistance, including insights from SITC on primary and secondary resistance. The discussion will also highlight the implications for clinical trial design and strategies to overcome resistance in melanoma therapy. Updates on emerging treatment opt...
2025-01-2432 min
PeerVoice Internal Medicine AudioMichael K. Wong, MD, PhD, FRCPC - When Anti-PD1 Therapy Fails: Could Oncolytic Immunotherapy Impact Outcomes in Advanced Melanoma?Michael K. Wong, MD, PhD, FRCPC - When Anti-PD1 Therapy Fails: Could Oncolytic Immunotherapy Impact Outcomes in Advanced Melanoma?
2024-12-1455 min
PeerVoice Internal Medicine VideoMichael K. Wong, MD, PhD, FRCPC - When Anti-PD1 Therapy Fails: Could Oncolytic Immunotherapy Impact Outcomes in Advanced Melanoma?Michael K. Wong, MD, PhD, FRCPC - When Anti-PD1 Therapy Fails: Could Oncolytic Immunotherapy Impact Outcomes in Advanced Melanoma?
2024-12-1410 min
PeerVoice Oncology & Haematology VideoMichael K. Wong, MD, PhD, FRCPC - When Anti-PD1 Therapy Fails: Could Oncolytic Immunotherapy Impact Outcomes in Advanced Melanoma?Michael K. Wong, MD, PhD, FRCPC - When Anti-PD1 Therapy Fails: Could Oncolytic Immunotherapy Impact Outcomes in Advanced Melanoma?
2024-12-1410 min
PeerVoice Oncology & Haematology AudioMichael K. Wong, MD, PhD, FRCPC - When Anti-PD1 Therapy Fails: Could Oncolytic Immunotherapy Impact Outcomes in Advanced Melanoma?Michael K. Wong, MD, PhD, FRCPC - When Anti-PD1 Therapy Fails: Could Oncolytic Immunotherapy Impact Outcomes in Advanced Melanoma?
2024-12-1455 min
英语万花筒 | 英语精讲「双 11」收官：天猫京东数据创新高 | 马斯克：特斯拉改进 Optimus 机器人设计以实现量产"Double 11" Concludes: Record-Breaking Sales Data from Tmall and JD.com「双 11」收官：天猫京东数据创新高This year's "Double 11" concluded without major e-commerce platforms releasing GMV figures.今年「双 11」结束后，各大电商平台未公布 GMV 相关数据。According to Tmall, by midnight on November 11, 402 brands had reached sales exceeding 100 million yuan, with 243 of them being domestic brands.天猫表示，截至 11 月 11 日零点，共有 402 个品牌成交额破亿，其中 243 个是国货品牌。Around 38,000 brands experienced year-over-year sales growth of over 100%.约 3.8 万个品牌的成交额同比增长超过 100%。Tmall's total users surpassed 800 million, while the 88VIP user count reached 32 million.天猫的全周期访问用户数突破 8 亿，88VIP 用户数也达 3200 万。JD.com also reported record-breaking sales and order volume for this year's Double 11 by 11:59 PM on November 11.京东同样在 11 月 11 日晚表示今年「双 11」成交额和订单量创新高，销售表现强劲。Over 60 brands had sales exceeding 1 billion yuan, with nearly 20,000 brands achieving a threefold increase in sales compared to the previous year.超过 60 个品牌销售额破 10 亿，接近 2 万个品牌同比增长超 3 倍。China Air Show: Global Debut of the Twin-Seat J-20S Stealth Fighter中国航展：歼-20...
2024-11-1304 min
Player Development First Podcast#13 Jeremy Elder, Soccer InnovationsThe First Player Development First podcast Video Episode! In this Episode Gregg interviews Jeremy Elder Owner of Soccer Innovations, a sports equipment manufacturer based in Dallas Texas. Jeremy talks about his youth experiences within soccer, his entrepreneurial journey and how he took over the family business and has taken soccer innovations to new heights. They also discuss some of soccer innovations products.
2023-09-1731 min
2023-04-1012 min
2023-04-1012 min
Player Development First Podcast#12 Kurtis Smith - Hudson Valley Community College Women’s Soccer program Head coach and NY Shockers Women’s Team Head coachIn episode 12 we have Kurtis Smith who is the Hudson Valley Community College Women’s Soccer program Head coach and NY Shockers Women’s Team Head coach and who also works with Beestera Soccer Training co-ordinating thier team training programs. He also takes a lot of private training sessions and works on camps and clinics through that organization.
2023-02-2036 min
Player Development First Podcast#11 Phil Phillipou: Alicante City FC Director of MethodologyIn this Episode Gregg talks with Phil Phillipou, who is the Alicante City FC Director of Methodology. Phil got started coaching at a young age with Crystal Palace with community coaching before going to the university of south Wales and working within Cardiff City's academy, he then went to the United states working within UK Elite soccer. Wanting to further his education he undertook a football studies Masters at Escuela Universitaria Real Madrid Universidad Europa. He now lives in Alicante with his current role.
2023-02-0639 min
Player Development First Podcast#10 Ian Wing: Head Coach of Dutchess Community College Mens ProgramToday Ian Wing and Gregg Megaw discuss Ians introduction to Soccer, the timeline of his coaching roles in New York state and his current role of Director of coaching at East Fishkill Soccer Club. We also discuss how he got into college coaching, botH his volunteering and roles in an assistant capacity before taking a head coaching job at Dutchess Community college. We also discuss how children playing multiple sports with juggling competitive soccer.
2023-01-3046 min
Player Development First Podcast#9 Stuart Harte: Playing Career and Coaching experiences in the USIn episode 9 we have on Stuart Harte, who talks about his playing experiences as a young professional in England with Bristol Rovers, his journey through the english football league and into the conference and his experiences as a youth coach and Director of Coaching in Oakland California, he also discusses parent education within his club environment.
2023-01-2454 min
Player Development First Podcast#8 Austin Ardrey - "Fast Twitch SPP" Speed Development for Soccer PlayersIn This Episode Austin Ardrey and Gregg Discuss how soccer players can benefit from speed development training, how coaches can implement speed training into their practice, pre game warm up activities, the importance of Speed reserve and injury prevention. We also discuss Austin's background and future goals with his online Speed school and having a speed specific facility. Anyone interested in Speed training with Fast Twitch SPP contact fasttwitchspp@gmail.com or find him on social media @fasttwitchspp
2023-01-2037 min
Player Development First Podcast#7 Ben Scott: Player Enjoyment, Development and Sideline BehaviorToday Ben Scott and Gregg Megaw discuss issues within sideline behavior from coaches and parents and how it impacts the players enjoyment and the development environment.
2023-01-171h 03
Player Development First Podcast#6 Wayne Drummond: Playing Career with Millwall and Glasgow Rangers.In this episode, Wayne discusses his playing career playing for Millwall as a Scholar, getting his first professional contract with Glasgow Rangers and getting representative honors playing within the Northern Ireland set up. Wayne also discusses his time playing with clubs within the Irish league and gives advice to young goalkeepers.
2022-10-1450 min
Player Development First Podcast#5 Orman Okunaiya: (Part 1) Professional Playing and Coaching Experiences in South East AsiaIn Episode #5 We have Orman Okunaiya who is currently the First Team and U23 Assistant coach at Qatar Sports Club in the Qatar Starts League. He played professional soccer in the Philipines for Ceres Football Club and was also played and became assistant first team coach at Bhanyankara FC in Indonesia. Orman Holds the UEFA B License and is a candidate on the UEFA A license.
2022-05-131h 13
Player Development First Podcast#4 Michael Carroll: Possession methodology with the younger age groupsIn Episode 4 we have Michael Carroll, who is the Player development director at SG1 Soccer Club in Katy, TX. Michael gives his career timeline and what his role as Player Development Director entails. He elaborates on what one of his sessions look like at u6, u7, u8 age groups, how he structures the practice and how he adds complexity to the activities as players develop. He also explains the why behind his methodology and how he encourages player decision making.
2022-05-0959 min
Player Development First Podcast#3 Ivan Gonzalez: Boys Academy Director at SG1 Soccer ClubIn Episode 3 we have Ivan Gonzalez who is the boy's Academy Director at SG1 Soccer Club in Katy, TX just outside of Houston. We hear about Ivan's coaching journey, SG1's methodology, his academy director role, what that entails on a weekly basis and his experiences with coaching education including U.S Soccer, La Liga and Tovo Courses.
2022-05-0246 min
Player Development First Podcast#2 Eoin Wearen: Coach Eoin Wearen on his professional playing experience within a premier league academy and his transition to coaching youth soccer in America.In episode 2 Gregg Megaw and Eoin Wearen discuss Eoin's playing career with West Ham United's academy, representing the Republic of Ireland and experiences within League of Ireland and Irish League sides. We also discuss Eoin's move to the U.S and his current role at Liverpool International Academy in Illinois
2022-04-181h 02
Player Development First Podcast#1 Ben Scott: Soccer Development at the Younger Ages (3-5)In our first episode, we discuss Ben’s introduction to coaching, his roles since moving to the United States to coach, his experiences on coaching licenses and youth soccer development at the younger ages. Ben is the Boys Director of Coaching at LMFC in Westchester County, NY, a staff coach at NCE and owns GB Soccer Coaching.
2022-04-1155 min
Jardinería Y Paisajismo (Oficial)>> 2 - ¿Qué tienen en común la cara de Rocky Balboa y el césped?El otro día estaba hablando con un amigo sobre las películas emblemáticas de los años 80 y discutíamos sobre la de Rocky Balboa, si era de ese período o de antes.
Y tan en duda estábamos que buscamos en el Big Brother (Google) para ver.
Resultó ser más vieja de lo que pensaba. Era de 1976.
Y recordando las escenas de las peleas, y el cómo le quedaba el rostro de tantos puñetazos.
Me acordé de lo destruido que queda, a veces, el césped cuand...
2022-01-1203 min
Jardinería y Paisajismo (Oficial)>> 2 - ¿Qué tienen en común la cara de Rocky Balboa y el césped?El otro día estaba hablando con un amigo sobre las películas emblemáticas de los años 80 y discutíamos sobre la de Rocky Balboa, si era de ese período o de antes.
Y tan en duda estábamos que buscamos en el Big Brother (Google) para ver.
Resultó ser más vieja de lo que pensaba. Era de 1976.
Y recordando las escenas de las peleas, y el cómo le quedaba el rostro de tantos puñetazos.
Me acordé de lo destruido que queda, a veces, el césped cuando se lo corta o siega.
Y se lo hace ma...
2022-01-1003 min
Blood PodcastImmune megakaryocytes, PD1 deletions in CTCL, and COVID-19 vaccine and VITTIn this week’s episode, we’ll review a study providing new insights on megakaryocyte diversity and function, including a unique subpopulation that may act as immune cells. Next, we’ll review research that intriguingly reveals a putative role for the PD1 gene in cutaneous T-cell lymphoma. Lastly, we’ll conclude with a report demonstrating a lack of cross-reaction between the antibodies that cause vaccine-induced thrombocytopenia and thrombosis, and the COVID-19 spike protein.
2021-10-0719 min
Digital Pathology Podcast27: Immuno-oncology 101 w/ Elfirede Nößner, HelmholzZentrum, Visiopharm advisorSend us a textThis episode is brought to you by VisiopharmCancer immunotherapy, aka immuno-oncology, is tapping into the power of our own immune system to fight cancer. There are multiple processes and immune cell populations involved in tumor immunology and digital pathology and whole slide imaging has allowed scientists to leverage the power of tissue image analysis to detect and quantify them.Today’s podcast guest, Prof. Elfriede Noessner will walk us through the complexities of the immune system, explain how it is being influenced to cure cancer and what role ti...
2021-09-0634 min
Shane Plays Geek TalkChiptunes with Matt Lister aka Cobra Commander - Episode 246 - 9-1-2021Matt Lister aka Cobra Commander joins to talk chiptune music, retrocomputing, and some classic G.I. Joe and Transformers. Trackers, hardware, and sound chips, oh my! What is MIDI (and can MIDI be chiptunes)? PAL, NTSC and electron guns. Atari 2600 game development and racing the beam. Yars' Revenge had very tricky programming. Behold the Casio XW-PD1 Trackformer, aka the Millennium Falcon, and grovel before its amazingness. Shane Plays Geek Talk Episode #246 - 9/1/2021 Like what you hear? Support Shane Plays Geek Talk on Patreon! https://www.patreon.com/shaneplays Shane Plays Geek Talk is...
2021-09-011h 31
Titik Putih Podcast#SP2 Skandal Terbesar Dalam Sejarah Sepak BolaPengaturan skor, narkoba, judi, kriminal, dan perselingkuhan cukup melekat dengan sepak bola. Bahkan sejak PD1 sudah ada kasus yang mewarnai olahraga yang kita semua cintai ini.
Inilah side pitch, selamat mendengarkan.
2021-03-0851 min
The Chain: Protein Engineering PodcastEpisode 25: Innovations in Antibody Engineering to Generate Novel Cancer ImmunotherapiesChristian Klein is a longtime and key member of the protein and antibody community. In this episode, he speaks with Executive Conference Producer, Christina Lingham, on how the field has changed since their first collaboration. Dr. Klein offers an overview of the latest applications of bispecific antibodies, including the latest progress of clinical trials by Roche and others. He also explains how the PD1-X molecule is unique and can increase specificity of therapeutics even more.
2021-02-0514 min
South Indian Classical (Carnatic) Music Archive: Classes / LessonsPadumanabha (GEETHAM Class / Lesson) : Malahari; Triputa; PurandaradasaNotations -> http://www.shivkumar.org/music/varnams/index.html#geethamsRagam: Malahari (15th Melakartha Janyam)ARO: S R1 M1 PD1 S ||AVA: S D1 PM1 G2 R1 S ||Talam: Triputa (Chathurasra Jathi)Composer: Purandara DasaMeaning: Courtesy, Dr. Aruna TuragaPallavi:Padumanaabha Parama Purushaa Param Jyoti SwaroopaaVidhura Vandya Vimala Charita Vihanga AdirohanaAnupallavi:Udadhi Nivaasa Uraga Shayana Unnatonnata MahimaYadukulottama Yagnya Rakshaka Yagnya Shikshaka Raama NaamaCharanam:Vibheeshana Paalaka Namo...
2021-01-0428 minBlood PodcastSeason 1, Episode 51In this week’s episode, we will learn more about T-cells from SARS-CoV-2-infected individuals, review a study that describes the rapid clinical and histologic response to anti-PD1 first-line therapy in early-stage, unfavorable Hodgkin lymphoma, and discuss a meta-analysis and systematic review of outcomes of patients with hematologic malignancies and Covid-19.
2020-12-1717 minThe UromigosEpisode 67: The Third Uromigos Debate - PD1/VEGF vs PD1/CTLA4 for front line renal cancerDavid McDermott and Brian Rini debate treatment options in front line renal cancer. It's hard to identify any winners from this podcast.
2020-11-1728 min
Repensarte#28 T2 E6 "Des-marginando con Fray Héctor Álvarez (Pingui)"Fray Pingui (como le decimos los cercanos) nos relata su historia vocacional en torno a los "crotos" y marginados de nuestra sociedad. ¡Hermosa experiencia, no te la pierdas! Tema final: Cristóbal Fones "Amigos de publicanos" (temaiken 😎) pd1: Se grabó con retorno 😫 pd:2 Cuando decimos "crotos" no es de modo despectivo, sino que se hace referencia al dicho popular de los años 20, cuando fue aprobada la ley de "Crotto" que le permitía viajar gratis en tren a todos los vagabundos de aquel tiempo. 👍
2020-10-2644 min
The Oncology PodcastThe Oncology Journal Club Episode 11: I-SPY2, National Lung Matrix Trial, #MedBikini, Quick Bites plus Guest Interview with Professor Dorothy Keefe, CEO of Cancer AustraliaSend us a textThe Oncology Journal Club - Delivering Oncology News DifferentlyThe Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 11 in our series The Oncology Journal Club.Today’s episode includes an in-depth review of two key papers – Eva talks us through the I-SPY 2 trial and Hans is focused on the National Lung Matrix trial. Eva also has her 'mind boggling' paper of the week on the #MedBikini controversy. This week we are very lucky to have a special interview with the i...
2020-08-2339 min
Malaria Minute | The Latest Malaria News, in 60 SecondsPeptide-Based PD1 Antagonist Stimulates T Cell ResponsesThe Latest Malaria News, in 60 Seconds.
A peptide derived from Bacillus bacteria stimulates the production of T cells prophylactically and therapeutically, and researchers explore the use of satellite imagery to assess the suitability of malaria vectors in different geographies.
More: www.fightmalaria.uk/MalariaMinute
2020-08-1401 min
The Stem Cell PodcastEp. 173: “Blood Cells and the Bone Marrow” Featuring Dr. Dominique Bonnet
Guest:
Dr. Dominique Bonnet is the Group Leader of the Hematopoietic Stem Cell Laboratory at the Francis Crick Institute in London, UK. Her lab is interested in the extrinsic mechanisms that regulate hematopoietic stem cells, and how they can intervene in order to eradicate the leukemic stem cell.
Featured Products and Resources:
Science News by STEMCELL Technologies
MesenCult™-ACF-Plus medium
The Stem Cell Science Round Up
Tiny CRISPR System Discovered – A very compact CRISPR-Cas system has been identified in huge bacteriophages, which provides an addition to the genome editi...
2020-07-281h 10
2020-06-0414 min
La Casa esta en Orden5) Los libertarios y el absolutismo de los derechos en cuarentenaEn este Podcast, hablare respecto a un analisis realizado por mi persona respecto a los que denomino "libertarios" y hablo del absolutismo de los derechos. ¿los derechos son o no son absolutos? ¿quienes son los libertarios?. Son preguntas que dare a conocer su respuesta en el podcast, son bienvenidos a escucharlo.
PD1: Feliz Cumpleaños a mi viejo y espero que tengamos un gran día
2020-05-3012 min
PODC’AFUF9.#VESSIE L' IMMUNOTHERAPIE - Pr YANN NEUZILLETEn 2 mots comment ça marche ? PD1-PDL1, CTLA4… c’est quoi tout ça ?Pourquoi faire de l’immunothérapie précocement ?Comment ça se passe en pratique ?Comment gérer les complications ?Le Professeur Yann Neuzillet (Hôpital Foch - Suresnes) répond à toutes vos questions !L’orateur n’a pas reçu de rémunération pour la réalisation de cet épisode.Pour aller plus loin :Pourquoi l'urologue doit s'intéresser à l'immunothérapie, quelles sont les indications établies en 2018 et celles en perspectives ? https://doi.org/1...
2020-04-2905 min
souforce.cloud#117 - Como se preparar para Certificação Beta PD1#117 - Como se preparar para Certificação Beta PD1 - Transmitido ao vivo no Instagram em 10/12/2019.
- Trilha de DEV1
- Focusonforce
- Quando errar uma questão do simulado, estude sobre o tema e não decore respostas
- Roteiro de estudos
- Uma boa noite de sono
- Fuja dos DUMPS
- Inglês
- Faça os módulos de renovação
Acompanhe, live de segunda a sexta às 21:41 no instagram mais perto de v...
2020-03-1532 min
PharmaTalkRadioPD1 Resistance with a Multi-Omic ApproachAnti-PD-1 therapy has transformed cancer care but most patients do not respond. It is increasingly clear that there will be no single biomarker of response to a PD-1, and that a multi-omic approach will be required. In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Danny Wells, Parker Institute for Cancer Immunotherapy will address: Orthogonality and correlation of response biomarkers across histologiesIntegration of multi-omic data sets for mechanistic insights into tumor immunobiologyThe translational approaches to PD1 resistance program at the Parker Institute To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com
2020-03-1024 min
Journal of Clinical Oncology (JCO) PodcastHigh Reward, High Toxicity: Combination Pembrolizumab and Lenvatinib in Advanced Endometrial CancerThe combination of pembrolizumab and lenvatinib is a promising second line option for metastatic or recurrent MSS endometrial cancer, although there can be considerable toxicity and choosing appropriate patients is key. TRANSCRIPT This JCO Podcast provides observations and commentary on the JCO article "Lenvatinib and Pembrolizumab in Patients With Advanced Endometrial Cancer" by Makker et al. My name is Meghan Shea, and I am an Instructor of Medicine at Harvard Medical School at Beth Israel Deaconess Medical Center in Boston, Massachusetts. My oncologic specialty is gynecologic oncology. Patients with advanced endometrial...
2020-03-0107 min
Circulation on the RunCirculation December 17, 2019 IssueDr Carolyn Lam: Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to the journal and it's editors. I'm Dr Carolyn Lam, Associate Editor from the National Heart center and Duke National University of Singapore. Dr Greg Hundley: And I'm associate editor, Dr Greg Hundley, from VCU Health, the Pauley Heart Center, in Richmond, Virginia. Well Carolyn, our feature discussion, are results from the Odyssey study and they're presented by Professor Wouter Jukema from Leiden University Medical Center, regarding the relationship between ultra-low LDL levels in both ischemic and hemorrhagic stroke...
2019-12-1620 min
Clinical Papers Podcast#32 - KEYNOTE-048 - Pembrolizumab com ou sem QT para tratamento de CEC de cabeça e pescoço O KEYNOTE-048 foi um estudo publicado na LANCET em outubro deste ano de 2019 onde comparou pembrolizumab com ou sem quimioterapia vs. um terceiro braço de quimioterapia com cetuximab (esquema este oriundo de um estudo chamado EXTREME) como controle, para pacientes com carcinoma espinocelular recorrente ou metastático de cabeça e pescoço. Este estudo tem um desenho muito complexo com várias análises estatísticas de modo que vale muito a pena você ouvir um modo simplificado e fácil sobre o tema. Eu e Tiago contamos com a ajuda do nosso colega Felipe Roitberg para este epis...
2019-11-3030 min
VIVIENDO LIBRE(Mente) La verdadera revolución en tu vida empieza aquí Entrenamiento Mental.Te cuento cosas importantes que después de muchos años de formación, se que te van a ahorrar muchos disgustos y estados de infelicidad.
Después de formarme como coach y de trabajar con cientos de personas tanto a nivel deportivo como a nivel personal y profesional, después de leer muchos libros y de escuchar muchas conferencias y acudir a cursos, he de decirte que la verdadera revolución, el verdadero cambio interior, se consigue de forma más efectiva y duradera, gracias al Entrenamiento Mental.
A la capacidad de enfocar a la mente, en los pensamientos adecuad...
2019-07-0609 min
VIVIENDO LIBRE(Mente) Tu mente necesita saber esto.¿Y si tu mente necesitará saber algo muy importante para ella y para ti?
Información con la que podrás realizar cambios en tu subconsciente y mejorar las áreas más complejas de tu vida.
Hoy, voy a hablarte de un tema muy importante que has de comunicar a tu mente.
Si, si, has de comunicar a tu mente, hacerla consciente de lo que voy a decirte.
Pero antes de ello, quería recordarte que en mi audio anterior, te propuse un ejercicio muy revelador para que te dieras cuenta del poco control que tienes sobre muchos de los pensamie...
2019-07-0607 min
2019-06-2608 min
Blood & CancerLung cancer: PD, PDL-1, and immunotherapyHoward “Skip” Burris, MD, the chief medical officer of Sarah Cannon Cancer Institute in Nashville, Tenn., joins the podcast as the guest host for a discussion of PD1 and PDL1 in the treatment of lung cancer. Dr. Burris interviews Melissa Johnson, MD, the associate director of lung cancer research at Sarah Cannon. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University dives into the financial realities of cancer care. Show notes By Emily Bryer, DO, resident in the department of internal medicine, University of Pennsylvania, Philadelphia Programmed death ligand...
2019-05-1635 minNew therapeutic targets in the inflammatory microenvironmentIn this podcast, Editor Anna Berghoff speaks to Professor Eric Tartour (Department of Immunology; Hôpital Européen Georges Pompidou) about new therapeutic targets in the inflammatory microenvironment.
The introduction of immune checkpoint inhibitors introduced a new era of oncology. The CTLA4 or PD1/PDL1 axis targeting immune checkpoint inhibitors have shown remarkable and long lasting responses in a variety of tumor types, Here, the biology of immune checkpoint inhibitors is outlined including the main site of action for the different immune checkpoint inhibitor types. Further, other possible immune checkpoints like LAG3 and other cells types including macrophages and NK ce...
2017-09-0500 min
MediCom Oncology Clinical Pearls PodcastsHow does the safety profile of the new and emerging anti-PD 1 antibodies differ from chemotherapy?Listen as Dr. Alison Moskowitz discusses the safety profile of the new and emerging anti-PD1 antibodies and how this differs from traditional chemotherapy in just under two minutes.
2017-07-1201 min
PG1 PNL1PG1PNL1 PD1We sit down to watch a sneak preview of AMC's Preacher, but end up
talking military grade underwear and CW superhero foursomes. As you do.
Twitter us: @PG1PNL1
2016-05-1900 min
GRACEcastAre there Clinically Significant Differences Among Immune Checkpoint Inhibitors Treating Lung Cancer?Drs. Leora Horn, Ben Solomon, & Jack West consider whether the data suggest that the better tested PD1 and PD-L1 inhibitors have differences in activity or tolerability or are essentially interchangeable.
2015-11-0402 min
2015-01-2209 min
GRACEcastAre There PD1 Biomarkers in Kidney Cancer?Predictive biomarkers can indicate if a patient will respond to a particular therapy. Dr. Lauren Harshman discusses if researchers know of any biomarkers for kidney cancer patients taking PD1 inhibitor drugs.
2014-08-0302 min
GRACEcast Kidney Cancer VideoAre There PD1 Biomarkers in Kidney Cancer?Predictive biomarkers can indicate if a patient will respond to a particular therapy. Dr. Lauren Harshman discusses if researchers know of any biomarkers for kidney cancer patients taking PD1 inhibitor drugs.
2014-08-0300 min
GRACEcast Lung Cancer AudioWhat is PD1 and PDL1 in Kidney Cancer?Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.
2014-07-1503 minGRACEcast Radiation Oncology VideoWhat is PD1 and PDL1 in Kidney Cancer?Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.
2014-07-1503 minGRACEcast Pancreatic Cancer VideoWhat is PD1 and PDL1 in Kidney Cancer?Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.
2014-07-1503 minGRACEcast Treatments and Support VideoWhat is PD1 and PDL1 in Kidney Cancer?Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.
2014-07-1503 minGRACEcast ALL Subjects audio and videoWhat is PD1 and PDL1 in Kidney Cancer?Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.
2014-07-1503 minGRACEcast Cancer 101 AudioWhat is PD1 and PDL1 in Kidney Cancer?Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.
2014-07-1503 minGRACEcast Breast Cancer VideoWhat is PD1 and PDL1 in Kidney Cancer?Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.
2014-07-1503 minGRACEcast Kidney Cancer VideoWhat is PD1 and PDL1 in Kidney Cancer?Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.
2014-07-1503 minGRACEcastWhat is PD1 and PDL1 in Kidney Cancer?Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.
2014-07-1503 minGRACEcast Lung Cancer VideoWhat is PD1 and PDL1 in Kidney Cancer?Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.
2014-07-1503 min
GRACEcast Treatments and Support VideoThe Promise of PD1 Inhibitors in Kidney CancerResults from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.
2014-06-2603 minGRACEcast Cancer 101 AudioThe Promise of PD1 Inhibitors in Kidney CancerResults from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.
2014-06-2603 minGRACEcast Radiation Oncology VideoThe Promise of PD1 Inhibitors in Kidney CancerResults from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.
2014-06-2603 minGRACEcast Breast Cancer VideoThe Promise of PD1 Inhibitors in Kidney CancerResults from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.
2014-06-2603 minGRACEcast Lung Cancer VideoThe Promise of PD1 Inhibitors in Kidney CancerResults from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.
2014-06-2603 minGRACEcast Pancreatic Cancer VideoThe Promise of PD1 Inhibitors in Kidney CancerResults from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.
2014-06-2603 minGRACEcast Lung Cancer AudioThe Promise of PD1 Inhibitors in Kidney CancerResults from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.
2014-06-2603 minGRACEcast ALL Subjects audio and videoThe Promise of PD1 Inhibitors in Kidney CancerResults from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.
2014-06-2603 minGRACEcastThe Promise of PD1 Inhibitors in Kidney CancerResults from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.
2014-06-2603 minGRACEcast Kidney Cancer VideoThe Promise of PD1 Inhibitors in Kidney CancerResults from recent clinical trials looking into PD1 inhibitors of kidney cancer are giving patients and doctors reasons to be hopeful.
2014-06-2603 min
WWPH-FM (107.9 FM) PodcastsThe Golden Girls (pd1) 6-11-14The Golden Girls (pd1) with Sami Cirkus, Emma Turney, Dani Grochmal, Taylor Wasserman, Rebecca Schwartz and Abbey Tattle 6-11-14
2014-06-1445 min
PdC (2013)Stress Group Podcast Episodio 21: The Lords of PodcastSi quieres pasar miedo, mucho miedo, miedete del de verdad de la buena, de hacerse caquita en los pantalones, escucha el ¡¡¡¡¡PROGRAMA ESPECIAL HALLOWEEN DE STRESS GROUP PODCAST!!!!
Posiblemente la experiencia más aterradora que jamás vivirás.
Un nuevo tipo de terror, el terror podcastero, llega a la ciudad con Stress Group Podcast.
Cierren todas las puertas y ventanas, vigilen a sus hijos, a sus abuelos, padres, tíos, primas, esposos/ esposas, parejas sentimentales en general, perros, gatos y koalas.
Tenga a mano un cuchillo, machete o katana por lo que pueda suceder.
No habrán la puerta a nadie, n...
2013-10-311h 21
GRACEcastCan we harness our immune system to fight NSCLC?Drs. Mary Pinder, Nate Pennell, and Jack West discuss promising work on immune checkpoint inhibitors such as MPPL-3280A, an anti-PDL1 immune-based therapy, and anti-PD1 therapy nivolumab, in advanced NSCLC.
2013-06-1908 min
GRACEcastHighlights in Lung Cancer, 2013, Part 4: Squamous Cell NSCLC and antiPD1 Immunotherapy (video)Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, describes new targets for squamous cell non-small cell lung cancer and anti-PD1 immunotherapy that has emerged as one of the most promising new developments in lung cancer from 2012.
2013-03-3008 min
GRACEcastHighlights in Lung Cancer, 2013, Part 4: Squamous Cell NSCLC and antiPD1 Immunotherapy (audio)Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, describes new targets for squamous cell non-small cell lung cancer and anti-PD1 immunotherapy that has emerged as one of the most promising new developments in lung cancer from 2012.
2013-03-3008 min
GRACEcast Lung Cancer AudioHighlights in Lung Cancer, 2013, Part 4: Squamous Cell NSCLC and antiPD1 Immunotherapy (audio)Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, describes new targets for squamous cell non-small cell lung cancer and anti-PD1 immunotherapy that has emerged as one of the most promising new developments in lung cancer from 2012.
2013-03-3008 min
AOL Small Cap PodcastDave Patterson, Donner Metals (TSX-V:DON)AOL Finance and Agoracom features small cap newsmakers and innovators. In Episode 119 of the AOL Finance Small Cap podcast, AGORACOM interviews Mr. Dave Patterson, chairman and director of Donner Metals (TSX-V:DON). Mr. Patterson goes “Beyond the Press Release” to discuss NI 43-101 resource on PD1 deposit. Download This Episode View Company Website Visit Investor […]
2011-01-2724 min
Gooolcast!Gooolcast! Jornada 21¿Qué pasa? ¿Ya pensabáis que esta semana no había Gooolcast!? Pues nada de eso, aquí estamos con la Jornada 21. La Liga en la recta final, la Champions ya con finalistas y cada vez más candidatos a formar parte de los Lillo Boys. No podiamos dejar de hacer programa en una semana como esta. Y además con alineación de lujo: Fer, Guardameta y nuestro Kaká particular, Morais, que vuelve del ostracismo para dejarnos gotas de su calidad.De los mejores programas que hemos hecho hasta el momento. Prometido.Pd1: grabamos cuando el Atleti...
2010-04-3000 minGooolcast!Gooolcast! Jornada 20Hemos sido un equipo ofensivo muy inofensivoJuanma Lillo, el arte del fútbolDespues de la ausencia de la semana pasada (culpa de Sunne, por supuesto) volvemos mejor que nunca con la Jornada de 20 de Gooolcast! donde repasamos las tres últimas jornadas de Liga, hacemos nuestros pronosticos para las semifinales de la Champions y, sobre todo, nos reimos mucho y utilizamos lenguaje malsonante, como los hombres de verdad, como Maniche.Esta vez el podcast dura un poco más de una hora pero viene muy cargadito, no te vas a arrepentir si lo escuchas.
2010-04-2000 minGooolcast!Gooolcast! Jornada 17Después de una semana de ausencia por problemas técnicos vuelve Gooolcast! más fuerte y con más ganas que nunca. En esta Jornada 17 vuelven a ser baja nuestros Kaka y Benzema particulares (Alex y Morais) pero la clase media formada por Sunne, Guardameta y Fer cumple sobradamente.Durante los 50 minutos que dura el podcast de esta semana repasamos la Jornada 26 de la Liga BBVA (y hacemos una preview de la 27), analizamos los octavos de final de la Champions y la Europa League, le seguimos la pista a los Lillo Boys (anteriormente conocidos como Ídolos...
2010-03-1900 minGooolcast!Gooolcast! Jornada 5Ya está aquí, un poco antes de lo habitual, la quinta jornada de Gooolcast! que se corresponde con la decimotercera de la Liga, una jornada marcada por el Clásico entre Barcelona y Real Madrid del pasado domingo.Además de repasar todos los partidos de la jornada y analizar pormenorizadamente el Clásico hablamos del sorteo de los octavos de la Copa (vamos con el Alcorcón a muerte) y del Balón de Oro a Messi (no se lo han dado a Xavi a pesar de nuestra campaña). Para finalizar presentamos la jornada decimocu...
2009-12-0200 minGooolcast!Gooolcast! Jornada 4Calentamos motores para el nuevo partido del siglo, el clásico por antonomasia de nuestro fútbol ¿Irá el señor del bigote a ver al Barça? ¿Habrá nuevo lanzamiento de cochinillo?En esta jornada 4 de Gooolcast! repasamos la jornada 11 de la Liga BBVA así como la quinta de la Champions League y anticipamos la jornada 12 de la Liga, recordando que en los clásicos no siempre gana el fútbol y confiando en que el Real Madrid vuelva con orgullo a su casa.Al final del podcast desvelamos el futuro del mismo fuera del á...
2009-11-2800 min